Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

21-Deoxycortisone: A Novel Sensitive and Specific Newborn Screening Marker for Congenital Adrenal Hyperplasia.

International journal of neonatal screening·2026

Same author

A Survey of Current Australasian Practices in the Use of Residual Bloodspots for the Addition of a New Disorder to the Screening Panel.

International journal of neonatal screening·2026

Same author

Assessment of TREC-Based NBS SCID Reporting Practices for Harmonization of Results and Interpretation: A Global Survey.

The journal of allergy and clinical immunology. In practice·2026

Same author

Newborn Screening-A Worldwide Endeavour to Protect.

International journal of neonatal screening·2025

Same author

Expanded Steroid Profiling Identifies Novel Newborn Screening Markers for Congenital Adrenal Hyperplasia.

The Journal of clinical endocrinology and metabolism·2025

Same author

ISNS General Guidelines for Neonatal Bloodspot Screening 2025.

International journal of neonatal screening·2025

Same journal

"Gazing into the crystal ball of mortality prediction in conservative kidney care": Correspondence.

Annals of the Academy of Medicine, Singapore·2026

Same journal

Vascular stiffness and sepsis mortality: A promising signal in search of clinical relevance.

Annals of the Academy of Medicine, Singapore·2026

Same journal

Transcatheter aortic valve implantation for severe aortic regurgitation with Trilogy system: Initial Southeast Asia experience.

Annals of the Academy of Medicine, Singapore·2026

Same journal

Singapore expert consensus on optimising lipid-lowering strategies in acute coronary syndrome: A modified Delphi study.

Annals of the Academy of Medicine, Singapore·2026

Same journal

Association of estimated pulse wave velocity with 28-day mortality in sepsis: A MIMIC-IV study.

Annals of the Academy of Medicine, Singapore·2026

Same journal

Prognostic value of the monocyte-to-albumin ratio in nasopharyngeal carcinoma: A retrospective cohort study.

Annals of the Academy of Medicine, Singapore·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Minimising harm from newborn screening programmes.

Dianne Webster¹

¹National Testing Centre, P O Box 872, Auckland, New Zealand. DianneW@adhb.govt.nz

Annals of the Academy of Medicine, Singapore

|November 12, 2009

Summary

This summary is machine-generated.

Newborn screening programs aim to maximize benefits while minimizing harms like pain and inaccurate results. Strategies include proper timing, precise tests, and clear guidelines to ensure infant safety and effective screening.

More Related Videos

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

FISH for Pre-implantation Genetic Diagnosis

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Related Experiment Videos

Last Updated: Jun 18, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

FISH for Pre-implantation Genetic Diagnosis

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Area of Science:

Medical screening programs
Public health initiatives
Pediatric diagnostics

Background:

Newborn screening programs present a balance between maximizing health benefits and minimizing potential harms.
Harms include procedural pain, psychological distress from false results, and diagnostic errors.
Effective management requires addressing these challenges proactively.

Purpose of the Study:

To identify and outline strategies for minimizing harms associated with newborn screening.
To enhance the overall safety and efficacy of newborn screening programs.

Main Methods:

Review of existing protocols and challenges in newborn screening.
Analysis of factors contributing to false positive/negative results.
Identification of best practices for pain management and information dissemination.

Main Results:

Pain can be reduced through pain relief measures and trained personnel.
False results are minimized by correct sample timing, precise testing, and appropriate disorder definitions.
Anxiety is managed through information availability and clear communication.

Conclusions:

Optimizing newborn screening involves a multi-faceted approach to mitigate risks.
Continuous program audit is crucial for early problem detection and improvement.
Balancing benefits and harms ensures the integrity and effectiveness of screening programs.